دورية أكاديمية
Angio-seal used as a bailout for incomplete hemostasis after dual perclose ProGlide deployment in transcatheter aortic valve implantation
العنوان: | Angio-seal used as a bailout for incomplete hemostasis after dual perclose ProGlide deployment in transcatheter aortic valve implantation |
---|---|
المؤلفون: | Çakal, Beytullah, Çakal, Sinem, Karaca, Oğuz, Kızılırmak Yılmaz, Filiz, Güneş, Hacı Murat, Yıldırım, Arzu, Özcan, Özgür Ulaş, Güler, Yeliz, Boztosun, Bilal |
بيانات النشر: | Texas Heart Institute |
سنة النشر: | 2022 |
المجموعة: | İstanbul Medipol University Institutional Repository (DSpace@Medipol) |
مصطلحات موضوعية: | Peripheral Artery Diseases, Hemostasis, Vascular Access Device |
الوصف: | Background: The failure rate of vascular closure devices remains a significant cause of major vascular complications in contemporary transcatheter aortic valve implantation practice. Methods: This research aimed to evaluate use of the Angio-Seal device in a bailout context in the setting of incomplete hemostasis following use of dual Perclose ProGlide devices in patients undergoing transfemoral transcatheter aortic valve implantation. A total of 185 patients undergoing transfemoral transcatheter aortic valve implantation with either dual Per-close ProGlide (n = 139) or a combination of dual Perclose ProGlide and Angio-Seal (n = 46) were retrospectively analyzed. The baseline, procedural characteristics, and all outcomes (defined according to Valve Academic Research Consortium-2 criteria) were compared. Results: No significant differences were seen between the dual Perclose ProGlide vs dual Perclose ProGlide+Angio-Seal groups with regard to the in-hospital Valve Academic Research Consortium-2 primary end points of major vascular complications (n = 13 [9.4%] vs n = 2 [4.3%]; P =.36), minor vascular complications (n = 13 [9.4%] vs n = 8 [14.7%]; P =.14), major bleeding (n = 16 [11.5%] vs n = 2 [4.3%]; P =.25), and minor bleeding (n = 9 [6.5%] vs n = 5 [10.9%]; P =.34), with higher rates of hematoma in the dual Perclose ProGlide+Angio-Seal group (n = 4 [2.9%] vs n = 5 [10.9%]; P =.044). Conclusion: Finding from the current study suggest that adjunctive Angio-Seal deployment may be feasible and safe, especially in patients with incomplete hemostasis following dual Perclose ProGlide use, and can be an optimal “bailout” procedure. (Tex Heart Inst J. 2022;49(6):e217684). |
نوع الوثيقة: | article in journal/newspaper |
وصف الملف: | application/pdf |
اللغة: | English |
تدمد: | 0730-2347 |
العلاقة: | Texas Heart Institute Journal; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Çakal, B., Çakal, S., Karaca, O., Kızılırmak Yılmaz, F., Güneş, H. M., Yıldırım, A. . Boztosun, B. (2022). Angio-seal used as a bailout for incomplete hemostasis after dual perclose ProGlide deployment in transcatheter aortic valve implantation. Texas Heart Institute Journal, 49(6). https://doi.org/10.14503/THIJ-21-7684Test; https://doi.org/10.14503/THIJ-21-7684Test; https://hdl.handle.net/20.500.12511/10183Test; 49; Q4; 000899359200001; 2-s2.0-85144066677; Q3 |
DOI: | 10.14503/THIJ-21-7684 |
الإتاحة: | https://doi.org/20.500.12511/10183Test https://doi.org/10.14503/THIJ-21-7684Test https://hdl.handle.net/20.500.12511/10183Test |
حقوق: | info:eu-repo/semantics/openAccess |
رقم الانضمام: | edsbas.9F7E52C8 |
قاعدة البيانات: | BASE |
تدمد: | 07302347 |
---|---|
DOI: | 10.14503/THIJ-21-7684 |